Sort
261,768 grants matching “gene therapy”
Genetic Susceptibility for Breast Cancer Subtypes
$909,410Andrew Olshan · Roswell Park Cancer Institute Corp · P01 · FY2014 · CA
Regulatory T Cells in Autoimmune Disease
$909,305David A. Hafler · Brigham And Women'S Hospital · U19 · FY2008 · AI
Strategies for Prevention of Autoimmunity
$909,292Stanford University · U19 · FY2004 · DK
Retinal Gene Therapy
$909,201Zhijian Wu · National Eye Institute · ZIA · FY2014 · EY
MRDD Research Center
$909,201Karl H Pfenninger · University Of Colorado Denver · P30 · FY2007 · HD
Targeting undruggable RAS for cancer treatment
$909,182Channing J Der · Univ Of North Carolina Chapel Hill · R35 · FY2018 · CA
Small Molecule Inhibitors of PCSK9-Phase II
$909,169Salim Shah · Hingez Therapeutics, Inc. · R44 · FY2018 · HL
Small Molecule Inhibitors of PCSK9-Phase II
$909,169Salim Shah · Hingez Therapeutics, Inc. · R44 · FY2019 · HL
Restoring neuronal degradative capacity as a therapeutic strategy to treat Prion Disease
$909,090Sandra E Encalada · Scripps Research Institute, The · R01 · FY2025 · NS
Mediators of cancer cell homeostasis: intervention targets common to diverse types of cancer
$909,071Hartmut Land · University Of Rochester · R35 · FY2016 · CA
Pathophysiology of Human Blood Cells
$909,057David A Williams · Boston Children'S Hospital · T32 · FY2020 · HL
SCLERODERMA CYCLOPHOSPHAMIDE OR TRANSPLANTION STUDY (SCOT)
$909,052Keith Sullivan · Duke University · N01 · FY2014 · AI
Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence
$908,973Joshua Tisdell Schiffer · Fred Hutchinson Cancer Center · R56 · FY2023 · AI
Computational Tools For Bioinformatics And Genome Analysis
$908,951John I Powell · Center For Information Technology · ZIA · FY2012 · CT
Optimizing AAV delivery of bNAbs for HIV prevention
$908,948Matthew Ryan Gardner · Emory University · R01 · FY2024 · AI
Extended half-life GlyTR1 combined with checkpoint blockade for Cancer Immunotherapy
$908,910Michael Demetriou · Glytr Therapeutics, Inc. · R42 · FY2024 · CA
Alzheimer's disease genetic architecture in the Portuguese population
$908,823Rita Guerreiro · Van Andel Research Institute · R01 · FY2023 · AG
Project 3 - Animal Models Examining Neurovasculature
$908,768Berislav V Zlokovic · University Of Southern California · P01 · FY2022 · AG
Thwarting HIV evasion of antibody avidity with novel antibody architectures
$908,756Pamela J Bjorkman · California Institute Of Technology · DP1 · FY2012 · DA
Poxvirus Gene Expression and DNA Replication
$908,727Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
High throughput CAR-T potency assay based on functional and transcriptional measurements on single cell co-cultures
$908,687Benjamin Biron Yellen · Celldom, Inc. · R44 · FY2025 · CA
Determining the Fate of Transmembrane Proteins
$908,652Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Targeting Gq pathway in uveal melanoma
$908,647Xu Chen · University Of California, San Francisco · R01 · FY2025 · CA
Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study
$908,642Joshua Aiden Hill · Fred Hutchinson Cancer Center · U01 · FY2022 · CA
Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk
$908,629Cecilia M Shikuma · University Of Hawaii At Manoa · R01 · FY2009 · HL